A Substituição do Herói: Estudo Transversal sobre Terapêutica de Substituição de Heroína
DOI:
https://doi.org/10.51338/rppsm.295Palavras-chave:
Buprenorfina/uso terapêutico, Dependência da Heroína/tratamento, Metadona/uso terapêutico, Tratamento de Substituição de OpiáceosDownloads
Referências
European Monitoring Centre for Drugs and Drug Addiction. Drug‑related deaths and mortality in Europe: update from the EMCDDA expert network, Technical report. Publications Office of the European Union, Luxembourg. [consulted in 11/09/2021] Available from: https://www.emcdda.europa.eu/system/files/publications/13762/TD0221591ENN.pdf
European Monitoring Centre for Drugs and Drug Addiction. European Drug Report 2017: Trends and Developments. Publications Office of the European Union, Luxembourg. [consulted in 11/09/2021] Avaliable from: https://www.emcdda.europa.eu/publications/edr/trends‑developments/2017_en
World Health Organization. Guidelines for the psychosocially assisted pharmacological treatment of opioid dependence. Geneva: WHO; 2009.4. World Health Organization. Guidelines for the Psychosocially Assisted Pharmacological Treatment of Opioid Dependence. Geneva: WHO; 2009. [consulted in 11/09/2021] Available from: https://www.ncbi.nlm.nih.gov/books/NBK143185/
Substance Abuse and Mental Health Services Administration. Results from the 2012 National Survey on Drug Use and Health: Summary of National Findings. NSDUH Series H‑46, HHS Publication No. (SMA) 13‑4795. Rockville: Substance Abuse and Mental Health Services Administration; 2013.
Vigna‑Taglianti FD, Burroni P, Mathis F, Versino E, Beccaria F, Rotelli M, et al; VEdeTTE Study Group. Gender Differences in Heroin Addiction and Treatment: Results from the VEdeTTE Cohort. Subst Use Misuse. 2016;51:295‑309. doi: 10.3109/10826084.2015.1108339. DOI: https://doi.org/10.3109/10826084.2015.1108339
Cotton BP, Bryson WC, Lohman MC, Brooks JM, Bruce ML. Characteristics of Medicaid recipients in Methadone Maintenance Treatment: A comparison across the lifespan. J Subst Abuse Treat. 2018;92:40‑5. doi: 10.1016/j.jsat.2018.06.002. DOI: https://doi.org/10.1016/j.jsat.2018.06.002
Peles E, Kreek MJ, Kellogg S, Adelson M. High methadone dose significantly reduces cocaine use in methadone maintenance treatment (MMT) patients. J Addict Dis. 2006;25:43‑50. doi: 10.1300/J069v25n01_07. DOI: https://doi.org/10.1300/J069v25n01_07
Casadonte PP, Sullivan MA. 2013. Transfer from Methadone to Buprenorphine.. Providers’ clinical support system for medication assisted treatment, PCSS guidance. 2004 (Updated May 12, 2013). Available at https://pcssnow.org/wp‑content/uploads/2014/03/
PCSS‑MATGuidanceTransferMethadonetoBup.Casadonte.pdf
Castells X, Kosten TR, Capellà D, Vidal X, Colom J, Casas M. Efficacy of opiate maintenance therapy and adjunctive interventions for opioid dependence with comorbid cocaine use disorders: A systematic review and meta‑analysis of controlled clinical trials. Am J Drug Alcohol Abuse. 2009;35:339‑49. doi: 10.1080/00952990903108215. DOI: https://doi.org/10.1080/00952990903108215
